Orthobiologics market to grow by $2.02 bn

The orthobiologics market research report has been added to Technavio’s catalog. The market is anticipated to witness healthy growth at a CAGR of 7.01%. Advanced Medical Solutions Group Plc (UK), Akcome Medical Holdings Co. Ltd. (China), Anika Therapeutics Inc. (US), Arthrex Inc. (US), Bioventus LLC (US), Globus Medical Inc. (US), Johnson and Johnson Inc. (US), Medtronic Plc (Ireland), Nuvasive Inc. (US), and Stryker Corp. (US) are some of the dominant players likely to contribute to the significant growth in the market.

The orthobiologics market is driven by the increase in focus to reduce orthopedic surgeries and the increasing prevalence of orthopedic disorders coupled with an aging population. However, high costs and inadequate reimbursements for orthobiologics products and procedures can hamper the growth of the market during the next few years. PR Newswire